Bold Longevity Growth Fund is a Boston-based venture capital firm investing in growth-stage and later-stage U.S. companies at the intersection of aging biology, longevity, healthcare, biotechnology and artificial intelligence. It backs frontier biotechnologies targeting root causes of age-related disease and healthy lifespan extension, with portfolio exposure including Oura, Insilico Medicine, Colossal and BigHat Biosciences.